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 Summary statement 
Here we disclose the first demonstration of corticosteroid-induced heart disease in fish and show that 
the molecular basis of heart disease is conserved from fish to mammals. 
 
Abstract: 
Stress and elevated cortisol levels are associated with pathological heart growth and cardiovascular 
disease in humans and other mammals. We recently established a link between heritable variation in 
post-stress cortisol production and cardiac growth also in salmonid fish. A conserved stimulatory 
effect of the otherwise catabolic steroid hormone cortisol is likely implied, but has to date not been 
established experimentally. Furthermore, whereas cardiac growth is associated with failure of the 
mammalian heart, pathological cardiac hypertrophy has not previously been described in fish. Here we 
show that rainbow trout (Oncorhynchus mykiss) treated with cortisol in the food for 45 days have 
enlarged hearts with lower maximum stroke volume and cardiac output. In accordance with impaired 
cardiac performance, overall circulatory oxygen transporting capacity was diminished as indicated by 
reduced aerobic swimming performance. In contrast to the well-known adaptive/physiological heart 
growth observed in fish, cortisol-induced growth is maladaptive. Furthermore, the observed heart 
growth was associated with up-regulated signature genes of mammalian cardiac pathology, suggesting 
that signaling pathways mediating cortisol-induced cardiac remodeling in fish are conserved from fish 
to mammals. Altogether, we show that excessive cortisol can induce pathological cardiac remodeling. 
This is the first study to report and integrate the etiology, physiology and molecular biology of 
cortisol-induced pathological remodeling in fish.
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 Introduction 
Cardiovascular disease is the leading cause of death in the western world. In addition to classical risk 
factors (e.g. hypertension and elevated levels of blood cholesterol) epidemiological evidence and 
common folklore wisdom suggest an association between stress and coronary heart disease (CHD) risk 
in humans (Rosengren et al., 1991; Iso et al., 2002; Rosengren et al., 2004). It is also well known that 
individual variation in physiology and behavior (coping styles, or “personalities”) predicts disease 
outcome in both animal models and humans (Denollet et al., 1996). Mechanisms underlying stress-
induced cardiac pathology risk remain largely unknown; however, increased levels of the steroid 
hormone cortisol are believed to be important. For example, high cortisol responsiveness to stress is 
associated with a four-fold increased risk of cardiovascular morbidity and mortality in humans 
(Denollet, 2000) and clinical use of synthetic cortisol (i.e. cortisone, hydrocortisone, dexamethasone 
etc.) is associated with abnormal heart growth and other cardiovascular diseases (Souverein et al., 
2004). In mammalian experimental models, glucocorticoids like cortisol directly induce 
cardiomyocyte hypertrophy in vitro (Whitehurst et al., 1999; Ren et al., 2012)  and in vivo (Clark et 
al., 1982; de Vries et al., 2002; Jensen et al., 2002; Lumbers et al., 2005), indicating a direct role of 
cortisol in heart remodeling, growth and disease.  
Stress - and cortisol-induced cardiac hypertrophy may not be limited to mammals. Cardiac 
remodeling and deformities are commonly reported in farmed fish (Poppe et al., 2007), but a link 
between stress and development of such diseases has never been established. As in humans, the main 
glucocorticoid and stress hormone in salmonid fish is cortisol. We recently established a link between 
cortisol responsiveness to stress and cardiac remodeling in rainbow trout (Oncorhynchus mykiss) high 
(HR) and low (LR) responsive strains and wild-type brown trout (Salmo trutta) (Johansen et al., 2011). 
High post-stress cortisol production is also associated with a range of behavioral and cognitive traits 
indicating a reactive coping style (Øverli et al., 2005; Øverli et al., 2007; Sørensen et al., 2013), 
rendering the salmonids a productive model to study proximate physiological mechanisms underlying 
consistent trait associations (Khan et al., 2016).  Regarding cardiac function, individuals responding to 
stress with high cortisol levels (HR fish) have notably larger ventricles compared to individuals with a 
low cortisol response (LR fish).  
Combined, previous findings indicate a common mechanism behind cortisol associated heart 
growth in fish and mammals, suggesting either parallel evolution or conservation of important 
regulatory mechanisms. Of note, although cardiac hypertrophy is associated with failure of the 
mammalian heart (Lloyd-Jones et al., 2002), the concept of pathological cardiac hypertrophy has not 
been established in fish. In fact, cardiac growth is a routinely occurring phenomenon in many fishes 
including salmonids; and is generally considered an adaptive response that enhances myocardial 
mechanical performance and cardiac pumping capacity (Graham and Farrell, 1989) during e.g. 
seasonal cold acclimatization (Klaiman et al., 2011) and sexual maturation (Franklin and Davie, 
1992). Further, although an association between cortisol exposure and cardiac remodeling has been 
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 observed in fish and mammals, the direct effect of exogenous cortisol administration on cardiac 
morphology and function has, to our knowledge, not been investigated in fish.  
Here, we hypothesized that chronic exposure to high cortisol directly induces cardiac 
hypertrophy and impairs cardiac performance in rainbow trout. Further, we hypothesized that 
intracellular signaling pathways mediating cortisol-induced cardiac remodeling in fish are similar to 
those involved in pathological cardiac hypertrophy in mammals. 
 
Materials and methods 
Research animals and animal housing 
For 45 and 90 days of cortisol treatment juvenile rainbow trout (150 ± 29 g, mean ± s.d.), obtained 
from Store Restrup Fiskeri, Nibe, Denmark were used. Experiments were conducted at the Danish 
Technical University, Institute of Aquatic Resources, Hirtshals, Denmark. Prior to cortisol treatment, 
fish were kept in rearing tanks (1000 L) supplied with aerated tap water at 17 °C. Lighting was kept at 
a 14.5/9.5 h light/dark cycle. The fish were subsequently moved and randomly distributed to six 700 L 
cylinder tanks (45 fish per tank) and allowed to acclimatize for 5 days before the onset of cortisol 
treatment. During this period and throughout the experiment, the tanks were supplied with aerated 
recirculating water at 19 °C. Lighting was kept at a 14.5/9.5 h light/dark cycle. Fish were divided into 
four treatment groups: One tank received control feed for 45 days (n=45), one tank received control 
feed for 90 days (n=45), two duplicate tanks received cortisol-treated feed for 45 days (n=90) and two 
duplicate tanks received cortisol-treated feed for 90 days (n=90). Ethical approvals for the experiments 
were given by the Norwegian and Danish Animal Research Authorities with license numbers 
2012/33240 and 2014-15-2934-01041, respectively. 
For in vivo assessment of effects of cortisol-induced remodeling on cardiovascular 
performance, juvenile rainbow trout (420 ± 23 g, mean ± s.d. g), obtained from Antens laxodling AB, 
Alingsås, Sweden, were used. Experiments were conducted at the fish holding facilities at the 
Department of Biological and Environmental Sciences, University of Gothenburg, Sweden. Fish were 
kept in tanks supplied with partly recirculating UV-treated and bio-filtered fresh water at 8 °C prior to 
experimentation. Lighting was kept at a 12/12 h light/dark cycle. The experiments were covered by 
ethical permit 65-2012 with amendment 169-2013 from the local ethical committee in Gothenburg. 
For all experiments animals were randomly assigned to either a control or treatment group. 
Preparation of cortisol feed 
Cortisol treatment refers to oral administration of prefabricated food pellets coated with 
hydrocortisone. More precisely, this diet was prepared by dissolving 500 mg (dose modified from 
Sørensen et al. (2011) cortisol (hydrocortisone powder, Sigma-Aldrich, St. Louis, MO, USA) in 15 g 
rapeseed oil (First Price,  SuperGros A/S, Denmark) per kg pellets (EFICO Enviro 920, 3 mm or 6 mm 
(depending on fish size) Biomar, Brande, Denmark). This was mixed in a container rebuilt from an 
850 W electric cement mixer (174 L) and thorough mixing of the content was ensured by rotation of 
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 this mixer. The container was connected to a vacuum pump and in order for the cortisol to be absorbed 
into the pellets, a negative pressure of 0.9 Bar was applied before air was slowly let back into the 
container. Control feed was prepared in the same way but with pure rapeseed oil. 
In vivo cortisol treatment 
During acclimation, all fish were fed 0.8 % of their total body mass each day with commercial pellets 
(EFICO Enviro 920, 3.0 mm, Biomar, Brande, Denmark). At the onset of the experiment the feed was 
exchanged with pellets of the same brand and size but that had been coated with either rapeseed oil 
alone (control feed) or rapeseed oil and hydrocortisone (Sigma-Aldrich, St. Louis, MO, USA) and the 
fish were fed 0.8 % of their body mass daily, corresponding to a dose of 4 µg cortisol/g BW. 
Following 45 and 90 days of cortisol treatment cortisol treated fish appeared as healthy as control fish 
with no internal or external symptoms of pathogen infection. 
Physiological measurements and sampling 
For blood sampling, fish were lightly anaesthetized with 1 g l-1 MS-222 before a blood sample was 
collected from the caudal vein. The blood samples were centrifuged for 5 min at 4 °C, 8000 g and 
plasma was frozen and stored at -20 °C for later analysis of cortisol levels. Hearts from all 
experimental fish were surgically excised and the bulbus and atrium removed. The ventricles were 
blotted dry of blood and weighed on a precision weight scale and cardiosomatic index (CSI=ventricle 
wet weight/body weight), was calculated. Images of the ventricles were taken using a Canon EOS350 
digital camera (Canon, Tokyo, Japan) and processed in Adobe Photoshop CS3 (Adobe Systems Inc., 
San Jose, CA, USA).Ventricles were either stored on RNAlater® solution (Ambion, Austin, TX, 
USA) for 24 h at room temperature before they were stored at -20 °C for later qPCR mRNA analysis, 
put on freshly prepared 4 % Paraformaldehyde for MRI analysis or dried at 70 °C for 24 h for analysis 
of % water content.  
Plasma cortisol analysis  
Plasma cortisol was measured in a random selection of individuals treated with cortisol for 15 and 45 
days. Plasma cortisol was analyzed using a radioimmunoassay (RIA) based on the assay by Pottinger 
and Carrick (2001). In short, steroids were extracted with ethyl acetate (Merck, 1:5 plasma, ethyl 
acetate) prior to the RIA. 5-150 μl of extract was transferred to 1.5 ml eppendorf tubes. 50 μl aliquots 
containing approximately 16 000 cpm of [1,2,6,7-3H] cortisol (Amersham Pharmacia Biotech, Little 
Chalfront, UK, 60 Ci mmol-1) was added to all samples. The ethyl acetate was evaporated in an 
exsiccator coupled to a water-jet pump and donkey anti-cortisol antibody (AbD Serotec, Dusseldorf, 
Germany) was added. After 18 h incubation at 4 °C, dextran-coated charcoal in PBS (1.0 % activated 
charcoal, Sigma; 0.2 % dextran, Sigma) was added. Supernatant from each tube was transferred to 
scintillation vials containing 4 ml scintillation fluid (Ultima Gold, Perkin Elmer, Waltham, MA, 
USA), and counted on a Packard Tri-Carb A1900 TR liquid scintillation analyzer (Packard Instrument, 
Meriden, CT, USA). A 3-parameter hyperbolic function was fitted to the plot of the percentage of 
3H-cortisol bound against a standard curve using SigmaPlot 11 (SPSS Science, Systat Software Inc., 
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 San Jose, CA, USA). The equation from this function was used to estimate the cortisol concentration 
in the unknown samples. The lower and upper detection limits of the assay were 0.19 and 655 ng/ml, 
respectively. For individuals where the plasma cortisol levels were below this limit, the level was set 
to 0.19 ng/ml.  
Magnetic resonance imaging (MRI) of fixed ventricles 
Ventricles fixed on 4 % PFA were thoroughly rinsed with saline water (0.4 %) before mounted with 
cotton and soaked in MRI-compatible perfluoropolyether oil (Fomblin, Sigma-Aldrich, St. Louis, MO, 
USA) in a 15 mm glass tube. “MRI experiments were performed on a pre-clinical 9.4 T MRI system 
(Agilent Technologies, Inc., USA) equipped with a high-performance gradient coil (inner diameter 
60 mm, max strength 1000 mT/m) and a quadrature RF volume coil ( 19 mm ID, Rapid Biomedical). 
High resolution images were acquired by 3D spoiled gradient echo. Field of view ranged from 12.8 × 
12.8 × 12.8 mm to 16 × 16 × 16 mm depending on the size of specimen. Other typical parameters were 
matrix 1024 ×512×512, repetition time TR 45 ms, echo time TE 10 ms, flip angle 450, 5 averages, 
acquisition time 16 h 23 min. Fiji image processing software (released under the General Public 
License) was employed to view the images and measure area of compact and non-compact 
myocardium. Area of compact myocardium was calculated by subtracting non-compact area (area 
inside of compact layer in the ventricle) form total area and non-compact area was calculated by 
subtracting compact area from non-compact area. Area of compact myocardium was then divided by 
the area of non-compact myocardium to get the ratio of compact to non-compact area. 
RNA extraction and qPCR analysis 
The hearts, stored and frozen in RNAlater®, were thawed and refrozen in liquid nitrogen before they 
were freeze-fractured in a BioPulverizer (Biospec Products, Inc., Bartlesville, OK, USA). The 
pulverized hearts were put into15 ml plastic tubes and RNA was extracted using TRIzol® reagent 
(Invitrogen, Carlsbad, CA, USA) according to the manufacturer’s protocol. The quality and quantity 
of the RNA was assessed using a 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA, USA) and a 
NanoDrop® ND-1000 UV-Vis Spectrophotometer (NanoDrop Technologies, Rockland, DE, USA), 
respectively. RNA quality was determined from RNA integrity numbers (RINs) calculated by the 2100 
Bioanalyzer (range: 1–10). The RIN for the tissue samples ranged from 8.4 to 10.0 with an average of 
9.5, confirming excellent RNA quality. First-strand cDNA was synthesized from total RNA treated 
with 2 ng DNase I (DNA-freeTM Kit, Ambion Applied Biosystems) using Superscript III reverse 
transcriptase (Invitrogen) with oligo dT12–18 primers synthesized by Invitrogen. Gene specific primer 
sequences for rainbow trout β-actin, proliferating cell nuclear antigen (PCNA), ventricular myosin 
heavy chain (VMHC), slow myosin light chain 2 (SMLC2), muscle LIM protein (MLP), regulator of 
calcineurin 1 (RCAN1), A-type natriuretic peptide (ANP) and B-type natriuretic peptide (BNP) were 
designed and published previously (Johansen et al., 2011). The housekeeping gene β-actin was used as 
reference gene. Real time PCRs were carried out using a Roche LC480 Light cycler (Roche 
Diagnostics, Penzberg, Germany). Reaction volumes were 10 µl and included Light cycler® 480 
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 SYBR Green I Master (Roche diagnostics GmbH, Mannheim, Germany), primers (5 µM) and cDNA 
(3 µM). Cycling conditions were as follows: 10 min at 95 °C, 42 cycles of 10 sec at 95 °C, 10 sec at 
60 °C and 10 sec at 72 °C followed by melt curve analysis. All reactions were run in duplicates and 
controls without DNA template were included to verify the absence of cDNA contamination.  
Relative gene expression data was calculated from real-time PCR raw data using the formula: 
ICECp/GOIECp= Expression of GOI in ratio to IC  
where IC is internal control (β-actin), GOI is gene of interest, E is priming efficiency, and Cp is 
crossing point. E values were calculated for each real-time RT PCR reaction using LinRegPCR 
software (version 11.30.0) (Ruijter et al., 2009). 
Surgical instrumentation for in vivo cardiovascular measurements 
Individual fish were netted from the holding tanks and anaesthetized in aerated water containing 
200 mg l-1 of tricaine methane sulphonate (MS-222; Sigma-Aldrich, Sweden) buffered with NaHCO3 
(400 mg l-1). The fish were weighed and placed on a surgery table covered with wet rubber foam. The 
gills were continuously irrigated via the mouth with aerated water (~10 °C) containing a lower dose of 
NaHCO3 buffered MS-222 (100 mg l-1 and 200 mg l-1, respectively). The right operculum was 
carefully retracted and the ventral aorta was surgically exposed taking care not to damage the 
pericardium and adjacent small blood vessels and nerves. A 4-0 silk suture was placed under the 
vessel, which was carefully lifted and a 2.5PSL or 2.5PSB Transonic perivascular blood flow probe 
(Transonic Systems Inc, Ithaca, New York, USA), factory-calibrated to 10 °C, was placed around the 
aorta to measure cardiac output (CO). The lead from the flow probe was sutured to the skin with 
several 2-0 silk sutures close to the opercular cavity. The dorsal aorta was then cannulated via the roof 
of the buccal cavity with a PE-50 catheter using a sharpened steel wire as guide (Axelsson and 
Fritsche, 1994). The catheter was rinsed and filled with heparinized (100 IU ml-1) saline (0.9 %) and 
closed with a pin. The catheter and the flow probe lead were collectively sutured to the skin at the 
back of the fish with a single 2-0 silk suture. Following surgery, fish were revived in fresh water in 
their respective holding tank and placed individually in a plastic tube floating in the tank. They were 
left to recover from surgery for approximately 24 h before experimentation commenced.  
Experimental protocol for in vivo cardiovascular measurements 
The fish was removed from the holding tube and transferred using a water-filled plastic bag to a round 
tank (diameter: 655 mm, volume: 75 l) supplied with through flowing water (8 °C). To trigger a 
maximal cardiovascular response, fish were subjected to a manual chase protocol where vigorous 
escape behaviours were encouraged by repeatedly touching the body of the fish for 10 min, making the 
fish completely unresponsive to physical stimuli at the end of the protocol. The fish was then rapidly 
transferred to an opaque holding chamber (length: 54, width: 13 and depth: 18 cm) with through 
flowing water from the same water system and covered to avoid external visual stimuli. A blood 
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 sample (0.5 ml) was quickly withdrawn into a heparinized syringe from the dorsal aortic cannula to 
determine maximal haematological status after stress and cardiovascular variables (maximal) were 
then recorded for 2-3 h after the chase protocol. The maximum cardiovascular response was defined as 
the period when cardiac output peaked after the exhaustive chase protocol. Typically, the maximum 
response occurred within 15 min and reported data represent the means from a 2 min period taken 
during the maximum response. 
 The following day, i.e. when the fish had recovered from the preceding exercise protocol for 
~24 h, basal cardiovascular variables were recorded for several hours. When low and stable 
cardiovascular variables had been confirmed another blood sample (0.5 ml) was withdrawn into a 
heparinized syringe from the catheter to determine basal haematological status. Cardiac autonomic 
tones were then determined using the pharmacological protocol of Altimiras et al. (1997). Briefly, 
atropine sulphate [1.2 mg kg body mass (Mb)-1] was first injected via the catheter to block muscarinic 
receptors and cardiovascular variables were allowed to stabilize for 30-60 min before a recording was 
made. Finally, (±) propranolol hydrochloride (3 mg kg Mb-1) was injected to block β-adrenergic 
receptors, and cardiovascular variables were allowed to stabilize for at least 30 min before a final 
recording was made. 
Acquisition of cardiovascular variables and analytical procedures  
The dorsal aortic catheter was connected to a DPT-6100 blood pressure transducer (pvb 
Medizintechnik, Kirchseeon, Germany) that was calibrated against a static column of water and 
referenced to the fluid in the holding tubes. A 4ChAmp pre-amplifier (Somedic AB, Hörby, Sweden) 
was used to amplify the signal from the transducer. The blood flow probe was connected to a three 
channel 400 series Transonic blood flow meter (Transonic Systems Inc, Ithaca, New York, USA). 
Data was sampled at 100 Hz using a Power Lab unit (ADInstruments Pty Ltd, Castle Hill, Australia) 
connected to a laptop computer running LabChart Pro software (version 7.3; ADInstruments Pty Ltd, 
Castle Hill, Australia). From the pulsatile blood pressure signal mean dorsal aortic blood pressure 
(PDA), diastolic pressure (PDA DIA), systolic pressure (PDA SYS), pulse pressure (PDA PULSE) and heart rate 
(fH) were calculated using the blood pressure module in the LabChart Pro software. Cardiac output 
(CO) was calculated from the phasic blood flow signal and based on these primary variables cardiac 
stroke volume (VS) was calculated as VS=Q/fH and systemic vascular resistance (RSYS) was calculated 
as RSYS = PDA/CO assuming that central venous blood pressure  is close to zero and that changes in 
venous pressure are negligible in these calculations (Sandblom and Axelsson, 2007).   
Blood haematocrit (Hct) was determined in duplicates using micro capillary tubes spun in a 
hematocrit centrifuge. Blood hemoglobin concentration (Hb) was determined using a Hemocue Hb 
201+ unit (Hemocue® AB, Ängelholm, Sweden) with values corrected for salmonid fish blood 
according to Clark et al. (2008).  
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 Experimental protocol for assessing swimming performance 
Critical swimming speeds were determined using a swimming respirometer as described previously 
(Skov et al., 2011). The swimming trials were were conducted at the Danish Technical University, 
Institute of Aquatic Resources, Hirtshals, Denmark and the temperature during trials were 19 C. 
Statistical analyses 
Data are expressed as group mean ± s.e.m. Differences between cortisol-treated and respective 
treatment controls were tested by one-way ANOVA (for differences in plasma cortisol levels), two-
way ANOVA (for effects of treatment and gender on CSI) or unpaired t-tests with welch`s correction 
for unequal variance when relevant.  Average CSI, relative compact to non-compact tissue and mRNA 
levels of control fish was normalized to 1, and data are presented as normalized values to treatment 
control average (fold change), whereas other data are presented as absolute values. P-values <0.05 
were considered statistically significant. For all experiments, a sample size ≥ 8 was used to ensure 
satisfactory statistical power. All statistical analyses were performed in GraphPad Prism 6 (GraphPad 
Software, San Diego, CA, USA). 
 
Results 
Chronic cortisol exposure induces cardiac hypertrophy in rainbow trout  
To test whether chronic cortisol exposure directly induces cardiac remodeling in salmonid fish, 
rainbow trout were fed cortisol-containing feed for 45 days. Increased plasma cortisol levels were 
confirmed after 15 and 45 days of cortisol treatment by one-way ANOVA (p<0.01). Plasma cortisol 
concentration after 15 days were 27.13 ± 8.2 µg/l vs. >0.19 ± 0.0 µg/l (below detection limit) in 
cortisol treated (n = 7) and controls (n = 5) respectively. After 45 days, plasma cortisol concentration 
equaled 20.38 ± s.e.m. µg/l vs 8.57 ± 1.99 µg/l in cortisol treated (n = 14) and controls (n = 14) 
respectively.   
Consistent with our hypothesis, 45 days of cortisol treatment resulted in a robust 34 % 
increase in CSI compared to controls (F(1,52)=80.93), p<0.001, Fig. IB). Mean CSI ± s.e.m. was 
0.085 ± 0.002 for controls and 0.11 ± 0.002 for cortisol treated fish. Since no gender differences were 
identified by the Two-way ANOVA (F(1,52)=0.09, p=0.77, Fig. S1), we did not separate between sexes 
in subsequent analyses.  
While visual inspection of ventricles gave a clear indication that these were larger in cortisol treated 
fish (illustrated in Fig. 1A), we also compared absolute ventricular weights and body weights in the 
two treatment groups following 45 days of treatment to exclude that the elevated CSI was attributed to 
reduced body weight. Indeed, absolute ventricular weights of cortisol-treated fish (0.22 ± 0.01 g) were 
higher than in controls (0.20 ± 0.01 g; p<0.05, Fig. 1C), despite absolute body weights being lower in 
the cortisol treated fish (198.1 ± 6.2 versus 238.4 ± 10.5 g, p<0.01, Fig. 1D). Thus, while cortisol 
induced substantial cardiac growth, overall somatic growth was stunted by the cortisol treatment. 
Jo
ur
na
l o
f E
xp
er
im
en
ta
l B
io
lo
gy
 •
 A
dv
an
ce
 a
rt
ic
le
 The salmonid heart consists of two separate layers of myocardium, i.e. spongious and compact 
myocardium. The inner spongious myocardium is supplied with blood from the venous circulation, 
while the outer compact myocardium resembles the mammalian myocardium and is supplied with 
blood from coronary arteries (Pieperhoff et al., 2009). The compact myocardium has a greater force-
generating capacity than the spongious myocardium. We therefore assessed the relative proportion of 
compact to non-compact volume in the two treatment groups by Magnetic resonance imaging (MRI) 
of the ventricles (see Fig. 1E). Interestingly, cortisol-treated fish had a higher proportion of compact to 
non-compact myocardial volume compared to controls (p<0.05, Fig. 1F), indicating that the cortisol-
induced cardiac growth is primarily due to growth of the compact myocardium. There was no 
significant difference in myocardial water content between controls and cortisol-treated fish, 
consistent with the increase in CSIs not resulting from myocardial tissue edema (Fig. 1G).   
  To indicate if the observed heart growth was due to hypertrophy or hyperplasia (i.e. cell 
proliferation) cardiac mRNA levels of the cell proliferation marker PCNA were measured. PCNA 
levels were not significantly increased by the cortisol treatment suggesting that cortisol-induced heart 
growth was driven mainly by hypertrophy (Fig. 1H).  
Hypertrophic remodeling is associated with increased expression signature molecules of cardiac 
pathology  
In mammals, including humans, pathological stimuli induce hypertrophic growth and remodeling of 
the heart characterized by up-regulation of specific molecular markers. We investigated the expression 
levels of SMLC2, VMHC, MLP, RCAN1, ANP and BNP in ventricles of rainbow trout treated with 
cortisol for 45 days. SMLC2 mRNA levels were doubled (p<0.05, Fig. 2A) in cortisol-treated fish 
whereas a trend towards increased VHHC was observed (p=0.14, Fig. 2B).  
The mammalian stress-sensor muscle LIM protein (MLP) was similarly upregulated (p<0.05, 
Fig. 2C) by the cortisol-treatment. MLP is necessary for stress-induced, pro-hypertrophic nuclear 
factor of activated T-cell (NFAT) signaling in mammals (Heineke et al., 2003). Calcineurin–NFAT 
signaling is a major pathway involved in mammalian pathological hypertrophy and remodeling and we 
assessed its activation by measuring mRNA levels of a direct downstream target gene of NFAT, 
RCAN1. Interestingly, RCAN1 mRNA levels were 102 % higher) than in respective controls 
following cortisol treatment (p<0.05, Fig. 2D). This indicates increased activation of pro-hypertrophic 
NFAT-signaling in rainbow trout hearts exposed to chronically elevated cortisol levels.  
 Natriuretic peptides are well-known signature molecules of heart failure progression in 
mammalian cardiac pathology (Lerman et al., 1993; Maisel et al., 2002). In line with a pathological 
transcriptional program profile of cardiac remodeling in cortisol treated rainbow trout, mRNA levels 
of A-type natriuretic peptide (ANP) was upregulated (Fig. 2E). mRNA levels of B-type natriuretic 
peptide (BNP) were not significantly changed (Fig. 2F).  
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 Chronic cortisol exposure impairs cardiovascular function and aerobic swimming performance 
in rainbow trout 
Upregulation of signature molecules of cardiac pathology, indicate that cortisol-induced heart growth 
is not functionally adaptive. To test this, cardiovascular scopes (i.e. the difference between maximum 
and resting values) were assessed in vivo in a separate cohort of rainbow trout treated with cortisol for 
45 days. To trigger a maximal cardiovascular response, fish were subjected to a period of exhaustive 
exercise. Maximum cardiovascular performance was assessed when cardiac output (CO) was maximal 
immediately after the exhaustive exercise. Resting cardiovascular values were then assessed following 
a 24 h recovery period.  
Despite having larger ventricles (mean CSI ± s.e.m. was 0.12 ± 0.009 vs. 0.085 ± 0.003 in 
cortisol treated (n=13) and control (n=20) fish, p<0.001) with more compact myocardium, maximum 
CO (p<0.05) was lower in cortisol-treated fish. Resting CO was not significantly changed but CO 
scope (p<0.05) was also lower in the cortisol group (Fig. 3A). Similarly, maximum but not resting 
stroke volume (VS) were lower in cortisol treated fish, and there was a clear trend (p=0.55) for a 
reduced VS scope (Fig. 3B). There was no significant difference in maximum heart rate (fH) between 
treatment groups, but resting fH was higher in cortisol-treated fish (p<0.05, Fig. 3C), which meant that 
the fH scope was reduced (p<0.05) in this group (Fig. 3C).  
The observed increase in resting heart rate could be caused by either altered cholinergic or 
adrenergic autonomic nervous input to the heart, or possibly by a cortisol-induced resetting of the 
cardiac pacemaker (i.e. the spontaneous intrinsic heart rate). Pharmacological agents were used to 
block muscarinic and β-adrenergic receptors to evaluate cholinergic and adrenergic tones and intrinsic 
heart rate (fH intr) following complete autonomic blockade (Altimiras et al., 1997). Indeed, cholinergic 
tone was decreased in cortisol-treated fish (Fig. 4A), whereas adrenergic tone and fH intr was not 
significantly altered (Fig. 4B). Thus, increased resting fH in cortisol-treated fish originated from 
decreased cholinergic inhibition.  
It is well known that factors such as blood viscosity and vascular resistance affect the 
workload of the hart. Elevated cardiac workload could possibly mediate the cardiac enlargement 
observed following cortisol treatment. Therefore, blood hematological variables such as hematocrit 
(Hct) and hemoglobin (Hb) content as well as hemodynamical variables such as systemic blood 
pressure and vascular resistance (RSYS) were investigated. Neither resting (Fig. 4C-D) nor maximum 
(Fig. 4E-F) Hct and Hb levels differed between control and cortisol treated fish (Fig. 4C-F) indicating 
that blood viscosity was similar in the two groups.   
Neither resting nor maximum systolic, diastolic or mean dorsal aortic blood pressures differed 
significantly between treatment groups (Fig. S2), but maximum RSYS was higher in cortisol treated fish 
(Fig. 4H). Resting RSYS was similar in both groups (Fig. 4G). 
Since cardiovascular oxygen transporting capacity is a strong determinant of maximum 
aerobic swimming capacity in fish (Claireaux et al., 2005), we also investigated if the impaired cardiac 
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 pumping capacity observed affected swimming performance. This was tested in a separate cohort of 
fish treated with cortisol for 90 days (mean CSI ± s.e.m. was 0.0782 ± 0.003 vs. 0.105 ± 0.003 in 
control (n=6) and cortisol treated (n=10) fish, p<0.0001). Indeed, maximum swimming performance 
(Ucrit) was reduced in the cortisol-treated fish  indicating that impaired cardiac function translates to a 
reduced overall physical performance (Fig 4I). 
 
Discussion 
In the present work, we showed that exogenous cortisol administration in rainbow trout induced 
substantial ventricular growth, likely through hypertrophy of the compact myocardium. These larger 
hearts generated lower maximum cardiac output (CO) and stroke volume (VS) with reduced CO scope. 
At the molecular level, cortisol–induced hypertrophic remodeling was associated with up-regulated 
signature genes of mammalian pathological hypertrophy, indicating that intracellular signaling 
pathways mediating cortisol-induced cardiac remodeling in fish are similar to those involved in 
pathological cardiac hypertrophy in mammals. Moreover, the observed cardiovascular changes were 
linked to reduced aerobic swimming capacity. Combined, our results are consistent with the 
hypothesis that elevated cortisol causes non-adaptive pathological cardiac hypertrophy, remodeling 
and dysfunction in rainbow trout. 
The current findings are in line with our previous finding that endogenous stress-induced 
cortisol production correlates with heart size and remodeling in rainbow trout (Johansen et al., 2011). 
Our previous investigations were performed on 40 months old (sexually mature) adults that had spent 
their entire lives under rearing conditions. It is therefore reasonable to assume that stress-induced 
cortisol production is sufficient to induce myocardial growth and remodeling in fish. Chronic stress 
has been shown to induce increases in plasma cortisol levels, comparable to those seen in the current 
study in both magnitude and duration (Barton and Iwama, 1991; Wendelaar Bonga, 1997). Thus, we 
believe that the current experimental protocol can be extrapolated to for example intensive aquaculture 
conditions. 
To our knowledge, only one previous study has investigated the effect of chronic cortisol 
administration on cardiac performance in fish. In line with our findings, Nesan and Vijayan (2012) 
reported that embryo exposure to chronically increased cortisol levels leads to cardiac performance 
dysfunction in Zebrafish (Danio rerio). In mammals, excessive glucocorticoids induce cardiomyocyte 
hypertrophy both in vitro (Ren et al., 2012) and in vivo (de Vries et al., 2002; Ahmed, 2013). Further, 
glucocorticoid-induced cardiac hypertrophy in rat myocytes and myocardium is associated with an 
increase in hypertrophy markers such as ANP and SMLC2 (De et al., 2011; Ren et al., 2012).  
In accordance with this, we found a consistent gene expression up-regulation of signature 
molecules of mammalian hypertrophy (i.e. ANP, SMLC2, MLP and RCAN1) in cortisol-treated 
rainbow trout ventricles. Several of these hypertrophy markers serve as specific molecular markers of 
pathological hypertrophy in humans. For example, ANP and SMLC2 are part of the fetal gene 
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 program, which is reinitiated during pathological cardiac hypertrophy and remodeling. Both genes are 
upregulated in pressure overload-induced hypertrophy in rats (Schiaffino et al., 1989) and human 
cardiac hypertrophy (Swynghedauw, 1999). Further, the cardiac stress sensor MLP is upregulated in 
several models of heart disease in rodents (Boateng et al., 2007) and necessary for stress-induced 
NFAT signaling (Heineke et al., 2003). 
 In mammals, extensive evidence exists showing that calcineurin-NFAT signaling is essential 
for and activated in pathological hypertrophy only (Wilkins et al., 2004). Since NFAT is a 
transcription factor, it`s activity can be measured by the mRNA expression of target genes, e.g. 
RCAN1 (Rothermel et al., 2001). In the current study, cortisol treatment induced an increase in 
RCAN1 mRNA expression, which is in line with previous findings of increased RCAN1 expression in 
rainbow trout with endogenously high plasma cortisol levels (Johansen et al., 2011). Combined, these 
data indicate pro-hypertrophic NFAT-signaling in the rainbow trout heart in response to chronic 
elevation of cortisol, and that NFAT signaling in pathological cardiac hypertrophy is conserved from 
fish to mammals.  
It is reasonable to speculate that cortisol can be involved in adaptive cardiac hypertrophy in 
salmonids given the right circumstances. Upon salmonid sexual maturation and spawning migration, 
plasma levels of corticosteroids peak (Schmidt and Idler, 1962). In fact, plasma levels of cortisol can 
be exceptionally high during spawning migration (chronically up to 640 ng/ml), similar to those 
occurring during chronic stress (Carruth et al., 2000). Interestingly, this hyper-activation of both the 
hypothalamus- pituitary-interrenal (HPI) - and gonadal (HPG) axes during migration coincides with 
massive cardiac growth. In contrast to the cardiac hypertrophy observed in the current study though, 
cardiac growth in migrating fish is associated with improved mechanical performance and cardiac 
pumping capacity (Franklin and Davie, 1992). One explanation could be that cortisol serves as a pro-
hypertrophic stimulus (Ren et al., 2012), but that other factors (e.g. anabolic sex steroids) are 
necessary for the hypertrophy to be accompanied by adaptive changes such as increased force 
generating capacity. Assuming such a role for cortisol, large increases in cortisol under different 
circumstances (such as for example during chronic stress), could potentially remodel the heart in a 
non-adaptive manner similar to the current observations. The exact combination of circumstances and 
exposure levels promoting adaptive vs maladaptive cardiac hypertrophy clearly deserves further 
scrutiny.  
The mechanism by which cortisol and glucocorticoids induce cardiac hypertrophy remains 
controversial. In mammals, cortisol can induce cardiac hypertrophy signaling by directly binding to 
nuclear receptors (ligand-inducible transcription factors) in the cardiomyocyte. Ren et al. (2012) 
showed that as many as 75 genes in the cardiac hypertrophy signaling pathway were altered by in vitro 
glucocorticoid treatment. Cortisol can, however, also act systemically by altering variables such as 
blood pressure, blood viscosity and/or vascular resistance and thereby increase the workload of the 
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 heart (Barton et al., 1987; Ahmed, 2013). We did not find any indications of increased blood viscosity 
since neither hematocrit nor hemoglobin were altered by cortisol treatment.  
In rodents, excessive glucocorticoids have been shown to induce hypertension (Ahmed, 2013) 
which is a major risk factor for pathological cardiac hypertrophy in mammals (Lloyd-Jones et al., 
2002). We did not see an increase in dorsal aortic blood pressure. However, systemic resistance was 
increased in cortisol treated fish. Ventral aortic blood pressure and branchial resistance are more direct 
measures of cardiac afterload, but increased systemic resistance has been shown to increase ventral 
and dorsal aortic blood pressure in trout (Conklin et al., 1997). Thus, our findings suggest that the 
observed increase in systemic resistance plays a role for mediating cardiac hypertrophy by elevating 
cardiac workload. In addition, increased systemic resistance can partly explain the reduced CO 
observed. Interestingly, cortisol treated fish appeared to compensate for the reduction in CO by 
increasing heart rate. 
The increased heart rate could reflect increased catecholaminergic innervation or decreased 
cholinergic tone on the heart. Reid et al. (1996) showed that cortisol administration in rainbow trout 
altered the secretion of catecholamines which are well known for their inotropic effects on the heart. 
By pharmacologically blocking both adrenergic and cholinergic receptors, we found that the increased 
heart rate in cortisol-treated fish was likely due to a reduction in cholinergic tone rather than an 
increase in adrenergic signaling.  
In summary, our results suggest a causative mechanism for the previously observed 
association between endogenous stress responsiveness and cardiac hypertrophy. This is the first study 
to report and integrate the etiology, physiology and molecular biology of cortisol-induced pathological 
remodeling in fish. Our data indicate cortisol and probably also stress as contributors to cardiac 
pathology in teleosts. Further, our data indicate that gene activation in pathological cardiac 
hypertrophy is evolutionarily conserved between fish and mammals. This in turn actualizes the 
question of why and how an apparently maladaptive trophic effect of an otherwise catabolic hormone 
is preserved in both piscine and tetrapod trajectories of vertebrate development.  
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 Figures 
 
 
Fig. 1. Chronic cortisol exposure increases ventricular size in rainbow trout. (A) Image of 
ventricles of control (325g body weight and 0.18 g ventricle weight, left) and fish treated with cortisol 
for 45 days (244 g body weight and 0.29 g ventricle weight, right). Scale bar, 1 cm. (B) Relative 
cardiosomatic index (CSI) (wet weight/body weight) following 45 days (45D) of cortisol treatment 
(n=28/group). (C) Absolute ventricle weight and (D) absolute body weight following 45 days of 
cortisol treatment (n=28/group). (E) Magnetic Resonance (MR)-image of cross sections of ventricles 
of control (600 g body weight and 0.44 g ventricle weight, left) and fish treated with cortisol for 45 
days (700 g body weight and 0.86 g ventricle weight, right). Scale bar, 1 cm. (F) Relative proportion 
of compact (comp) to non-compact (non-comp) myocardium following 45 days of cortisol treatment 
(n=21/group). (G) Percent (%) water content (g water/g wet weight*100) in ventricles following 45 
days of cortisol treatment (ncontrol=8, ncortisol=7). (H) mRNA abundance of Proliferating cell nuclear 
antigen (PCNA) relative to the standard gene β-actin following 45 0) days of cortisol treatment 
(ncontrol=9, ncortisol=10. Data are either means ± s.e.m. (C, D and G) or means ± s.e.m relative to 
treatment control (B, F and H). The mean CSI, ratio of comp to non-comp myocardium and PCNA 
expression of control fish were normalized to 1.Statistical differences were tested by Two-way 
ANOVA (for CSI) or unpaired two-tailed t-tests. *p<0.05 vs. control. 
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Figure 2. Cortisol-induced hypertrophic remodeling is associated with increased expression 
levels of signature molecules of cardiac pathology in rainbow trout. mRNA abundance of (A) slow 
myosin heavy chain 2 (SMLC2), (B) ventricular myosin heavy chain (VMHC), (C) muscle Lim 
Protein (MLP), (D) regulator of calcineurin 1 (RCAN1), (E) A-type natriuretic peptide (ANP) and (F) 
B-type natriuretic peptide relative to the standard gene β-actin following 45 days (45D) of cortisol 
treatment (ncontrol=9, ncortisol=10).  Data are means ± s.e.m relative to control. Statistical differences 
were tested by unpaired two-tailed t-tests. *p<0.05 vs. control.  
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Figure 3. Chronic cortisol exposure impairs cardiovascular function in rainbow trout.  
Maximum (A, upper panel, ncontrol=8, ncortisol=9) and resting (A, middle panel, ncontrol=5, ncortisol=9) 
cardiac output (CO), CO scope (A, lower panel, ncontrol=5, ncortisol=9), maximum (B, upper panel, 
ncontrol=8, ncortisol=9) and resting (B, middle panel, ncontrol=5, ncortisol=9) stroke volume (VS), VS scope 
(B, lower panel, ncontrol=5, ncortisol=9), maximum (C, upper panel, ncontrol=12, ncortisol=10) and resting 
(C, middle panel, ncontrol=9, ncortisol=10) heart rate (fH) and fH scope (C, lower panel, ncontrol=9, 
ncortisol=10) following 45 days (45D) of cortisol treatment is shown. Statistical differences were tested 
by unpaired two-tailed t-tests. *p<0.05, vs. control. 
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Figure 4. Hemodynamic and hematological variables and swimming performance following 
chronic cortisol exposure in rainbow trout. (A) Cholinergic and (B) adrenergic tone (n=9/group), 
resting (C) hematocrit and (D) hemoglobin (n=9/group), maximum (E) hematocrit and (F) 
hemoglobin (n=9/group) and (G) resting (ncontrol=5, ncortisol=9) and (H) maximum (ncontrol=7, 
ncortisol=9) systemic resistance (Rsys) following 45 days (45D) of cortisol treatment. (I) Swimming 
performance (Ucrit) following 90 days (90D) of cortisol treatment (ncontrol=6, ncortisol=10). Statistical 
differences were tested by unpaired two-tailed t-tests. *p<0.05, vs. control. 
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Supporting Figures 
 
Fig. S1. Effects of chronic cortisol administration on cardiosomatic index in male and female rainbow trout. 
Relative cardiosomatic index (CSI) (wet weight/body weight) following 45 days (45D) of cortisol treatment in male 
(ncontrol=16, ncortisol=17) and female (ncontrol=12, ncortisol=11) rainbow trout.  Data are means ± s.e.m. Statistical 
differences were tested by two-way ANOVA.  
Journal of Experimental Biology 220: doi:10.1242/jeb.135046: Supplementary information
Jo
ur
na
l o
f E
xp
er
im
en
ta
l B
io
lo
gy
 •
 S
up
pl
em
en
ta
ry
 in
fo
rm
at
io
n
 
Fig. S2. Effects of chronic cortisol administration on blood pressure in rainbow trout. Maximum (A, upper panel, 
ncontrol=11, ncortisol=10) and resting (A, middle panel, ncontrol=9, ncortisol=10) systolic blood pressure, systolic 
blood pressure scope (A, lower panel, ncontrol=9, ncortisol=10), maximum (B, upper panel, ncontrol=11, 
ncortisol=10) and resting (B, middle panel, ncontrol=9, ncortisol=10) diastolic blood pressure, diastolic blood 
pressure scope (B, lower panel, ncontrol=9, ncortisol=10), maximum (C, upper panel, ncontrol=11, ncortisol=10) 
and resting (C, middle panel, ncontrol=9, ncortisol=10) mean blood pressure and mean blood pressure scope (C, 
lower panel, ncontrol=9, ncortisol=10) following 45 days (45D) of cortisol treatment. Data are means ± s.e.m. 
Statistical differences were tested by unpaired t-tests. 
Journal of Experimental Biology 220: doi:10.1242/jeb.135046: Supplementary information
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